<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03110003</url>
  </required_header>
  <id_info>
    <org_study_id>F1605020005</org_study_id>
    <nct_id>NCT03110003</nct_id>
  </id_info>
  <brief_title>Bupivacaine With Epidural Volume Extension</brief_title>
  <official_title>Comparing Low-dose Bupivacaine With Epidural Volume Extension to Standard Bupivacaine Dosing for Short Obstetric Procedures: A Prospective, Randomized Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Alabama at Birmingham</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Alabama at Birmingham</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study the investigator will address the efficacy of using low dose bupivacaine spinal
      anesthesia (SA) in combination with epidural volume extension (EVE) for patients undergoing
      short obstetric procedures.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Due to risks to both the mother and fetus, neuraxial anesthesia - spinal, epidural, or
      combined spinal-epidural (CSE) - is preferred over general anesthesia for all obstetrical
      procedures. However, one downside to neuraxial anesthesia is the increased time patients have
      to stay in the post-anesthesia care unit (PACU) due to residual numbness from the neuraxial
      block. In this study, the investigators will address the efficacy of using low dose
      bupivacaine spinal anesthesia (SA) in combination with epidural volume extension (EVE) for
      patients undergoing short obstetric procedures. This will be accomplished by performing a CSE
      with: 1) injecting the local anesthesia in the spinal space; 2) injecting sterile saline into
      the epidural space to help increase the spread of the local anesthesia in the spinal space.
      The idea is that physicians will be able to use less local anesthetic due to getting a
      greater spread of medication. This lower amount of local anesthetic will lead to a decreased
      duration of the spinal block; therefore, it will significantly decrease PACU length of stay.
      This technique will be compared to our traditional dose of spinal anesthetic without EVE in
      the CSE. Both groups will have an epidural catheter in place to allow us to give any
      additional local anesthetic to keep the patient comfortable throughout the procedure if the
      spinal anesthesia begins to wear off. The aim of this study is to determine if low dose
      spinal bupivacaine in conjunction with EVE can decrease the PACU recovery time for short
      obstetric procedures while still providing an adequate surgical block.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 27, 2016</start_date>
  <completion_date type="Anticipated">June 2019</completion_date>
  <primary_completion_date type="Anticipated">June 2018</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time until PACU Discharge in minutes</measure>
    <time_frame>Baseline up to 48 hrs postoperatively</time_frame>
    <description>Time from entrance into the PACU until PACU discharge criteria met</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time elapsed to achieve T10 sensory level to pinprick in minutes</measure>
    <time_frame>Baseline up to 3 hours</time_frame>
    <description>Time elapsed until T10 sensory level achieved after placement of the block</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Degree of peak motor blockade by modified Bromage scale</measure>
    <time_frame>Baseline up to 3 hours</time_frame>
    <description>Motor blockade will be determined by the patient's ability to lift her legs</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time elapsed until motor block regresses to modified Bromgage Score &lt; 2</measure>
    <time_frame>Baseline up to 6 hours</time_frame>
    <description>Time until score of &lt;2 reached on Modified Bromage scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Block as determined by subjective pain assessment</measure>
    <time_frame>Baseline up to 6 hours</time_frame>
    <description>Determined by any pain reported during surgery and/or the need to supplement through the epidural</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction as determined by a Likert-type scale</measure>
    <time_frame>At 6 hrs postoperatively</time_frame>
    <description>Patient satisfaction of a scale of 1-10</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Spinal Anesthesia</condition>
  <condition>Epidural; Anesthesia</condition>
  <arm_group>
    <arm_group_label>10 mg Bupivacaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects will receive 10 mg of preservative-free isobaric bupivacaine with 12.5mcg of fentanyl.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>5 mg Bupivacaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects will receive 5 mg of preservative-free isobaric bupivacaine with 12.5mcg of fentanyl in combination with 10 mL of sterile saline injected into the epidural space.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>10 mg Bupivacaine</intervention_name>
    <description>10 mg of preservative-free isobaric bupivacaine with 12.5mcg of fentanyl injected to the epidural space</description>
    <arm_group_label>10 mg Bupivacaine</arm_group_label>
    <other_name>Marcaine and Sensorcaine</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>5 mg Bupivacaine</intervention_name>
    <description>5 mg of preservative-free isobaric bupivacaine with 12.5mcg of fentanyl in combination with 10 mL of sterile saline injected into the epidural space.</description>
    <arm_group_label>5 mg Bupivacaine</arm_group_label>
    <other_name>Marcaine and Sensorcaine</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients undergoing short obstetric procedure in the operating room requiring
             neuraxial anesthesia.

        Exclusion Criteria:

          -  coagulopathy

          -  platelets &lt;80,000

          -  allergy to local anesthetic or fentanyl

          -  previous spinal surgery

          -  spinal or intracranial mass

          -  history of lower extremity weakness
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mark Powell, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Alabama at Birmingham</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Betty Herard, MBA MA</last_name>
    <phone>205-934-0045</phone>
    <email>bherard@uabmc.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ayesha Bryant, MD</last_name>
    <phone>205-996-7383</phone>
    <email>asbryant@uabmc.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>UAB Department of Anesthesiology and Perioperative Medicine</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35249</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Betty Herard, MBA, MA</last_name>
      <phone>205-934-0045</phone>
      <email>bherard@uabmc.edu</email>
    </contact>
    <contact_backup>
      <last_name>Ayesha Bryant, MSPH, MD</last_name>
      <phone>205-996-7383</phone>
      <email>asbryant@uabmc.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Mark F Powell, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Promil Kukreja, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Christopher Blakely, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Michael Froelich, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Charity Morgan, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 30, 2017</study_first_submitted>
  <study_first_submitted_qc>April 5, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 12, 2017</study_first_posted>
  <last_update_submitted>April 11, 2018</last_update_submitted>
  <last_update_submitted_qc>April 11, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 13, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Alabama at Birmingham</investigator_affiliation>
    <investigator_full_name>Mark Powell</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Neuraxial epidural techniques</keyword>
  <keyword>Combined spinal epidural</keyword>
  <keyword>Epidural volume extension</keyword>
  <keyword>Transient Neurologic Symptoms (TNS)</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Fentanyl</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

